Study of the Drug Interaction of EYP001a With Entecavir in Healthy Subjects
This is a Phase 1, single-center, open-label, three subsequent dosing periods study to evaluate the drug-drug-interaction (DDI), pharmaco-kinetics (PK) and pharmacodynamics (PD), safety, and tolerability of a single dose of EYP100a combined with ETV in healthy men and women dosed in the morning under fasted conditions.
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose, Parallel-Group, Relative Bioavailability Study to Evaluate the Pharmacokinetics of ZYN002 (CBD) Following Application to the Skin of the Upper Arms/Shoulders Compared to Upper Arms/Shoulders and Upper Thighs
An Open-Label Study of the Safety and Tolerability of AeroFactTM (Aerosolized Alveofact®) in Preterm Infants on nCPAP at Risk for Worsening Respiratory Distress Syndrome.
100 Clinical Results associated with CPR Pharma Services Pty Ltd.
0 Patents (Medical) associated with CPR Pharma Services Pty Ltd.
100 Deals associated with CPR Pharma Services Pty Ltd.
100 Translational Medicine associated with CPR Pharma Services Pty Ltd.